The “Topical Analgesic Market” research report 2019-2024 focuses on provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data. Topical Analgesic Market report also provides the current industry outlook with respect to key players, types, applications, countries and regions. The major drivers, restraints, opportunities and threats for key players is also included. It also provides granular analysis of market share, segmentation, revenue forecasts and regional analysis till 2024.
Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14244423
Scope of the Report:
List of Key Manufacturers Covered in Topical Analgesic Market:
Topical Analgesic Market Report Covers the Following: –
- The report covers forecast and analysis for the market on a global and regional level.
- The report includes the drivers and the restraints that affect the growth of the market.
- The report discusses detailed information about the market opportunities.
- The market is segmented on the basis of product and end-user industry
- The key target audience for the market has been determined in the report.
- The revenue generated by the prominent industry players has been analyzed in the report.
For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14244423
Topical Analgesic Market Report Highlights:
- Comprehensive pricing analysis on the basis of product, application, and regional segments
- The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the Topical Analgesic market
- Deep insights about regulatory and investment scenarios of the Topical Analgesic market
- Analysis of market effect factors and their impact on the forecast and outlook of the Topical Analgesic market
- A roadmap of growth opportunities available in the Topical Analgesic market with the identification of key factors
- The exhaustive analysis of various trends of the Topical Analgesic market to help identify market developments
Key Market Trends:
Non-opioids are Expected to Hold Significant Market Share in the Drug Type
In recent years, with emerging chronic pain conditions, the topical route for pain management has seen a resurgence of interest, owing to its potential to deliver therapeutic doses of medication directly to a painful site, circumventing the GI tract, and without any requirement for a needle. Topical NSAIDs are found to be more effective in treating acute pain from strains, sprains, contusions, or overuse injuries in superficial locations. Various formulations of topical diclofenac are available in the market for the treatment of acute and chronic pain, including Voltaren gel, Pennsaid solution, and Flector patch, and are used in the setting of osteoarthritis or musculoskeletal pain. As per the recommendation of National Institute for Health and Care Excellence (NICE), topical NSAIDs in the first instance for joint pain associated with osteoarthritis, in preference to oral NSAIDs are prescribed by the healthcare professionals, owing to concerns over systemic side effects caused by the long term use of oral NSAIDs.
This makes topically applied NSAIDs to be the first choice for physicians in the initial treatment of pain and which further creates immense commercial opportunity in the present market.
The Market is Dominated by North America and is Expected to do Same in the Forecasted Period
North America is estimated to dominate the industry, owing to well-established healthcare facilities, rising geriatric population, and growing prevalence of chronic pain. In recent years, it has been found that pain affects more Americans than diabetes, heart disease, and cancer combined, which further influence adults to seek medical care. Pain is one of the key reasons behind the leading cause of disability and a major contributor to health care costs in the United States. As per the data provided by the Centers for Disease Control and Prevention (CDC), chronic pain range from 11% to 40% among the adults of the United States. The high prevalence of chronic pain thus indicates the importance of topical pain relief products and consequently helps to drive its market. Apart from this, the growing prevalence osteoarthritis acts as one of the key driving factors of the topical analgesic market in the United States, which affects around 30 million US adults. In the United States, the Food and Drug Administration (FDA) has approved several topical products that contain the prescription NSAID diclofenac in the form of gels, liquids, and patches for the treatment of osteoarthritis.
Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14244423
Detailed TOC of Topical Analgesic Market Report 2019-2024:
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Arthritis
4.2.2 Rising Cases of Sports related Injuries
4.2.3 Growing Geriatric Population
4.3 Market Restraints
4.3.1 Side Effects Related to Topical Analgesics
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Drug Type
5.1.1 Non Opioids
22.214.171.124 Nonsteroidal anti-inflammatory drugs (NSAIDS)
126.96.36.199 Methyl salicylates
188.8.131.52 Other Drug Types
5.1.3 Other Opioids
5.2.5 Other Formulations
5.3.1 Over the Counter (OTC) Analgesic
5.3.2 Prescription Analgesic
5.4.1 North America
184.108.40.206 United States
220.127.116.11 United Kingdom
18.104.22.168 Rest of Europe
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
5.4.4 Middle East & Africa
188.8.131.52 South Africa
184.108.40.206 Rest of MEA
5.4.5 South America
220.127.116.11 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AdvaCare Pharma
6.1.2 GlaxoSmithKline plc.
6.1.3 Johnson & Johnson
6.1.4 Pfizer Inc.
6.1.5 Hisamitsu Pharmaceutical co.,inc.
6.1.7 Sun Pharmaceutical Industries Ltd
6.1.8 Topical BioMedics, Inc.
6.1.9 Teva Pharmaceutical Industries Ltd
6.1.10 List Not Exhaustive
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Name: Ajay More
Phone: US +14242530807/ UK +44 20 3239 8187
Email: [email protected]
Our Other Reports: